Clinical trial

Excitotoxicity Markers and the Clinical-radiological Progression After a Demyelinating Event: a Prospective Pilot Study

NCT02523703

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-09-10

PhaseNA

Study timeline

Study start (actual)2007-09-10Date precision: day

Registry last updated2020-09-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

glutamate and aspartateBIOLOGICAL

Sponsors & collaborators

University Hospital, Caenlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02523703 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.